咖啡与帕金森病的联系
Abraham Olufemi Asuku1, Maryam Tayo Ayinla2, Tobiloba Samuel Olajide3
1Bioresources Development Centre, National Biotechnology Research and Development Agency, Ogbomoso, Oyo, Nigeria; Department of Physiology, Faculty of Basic Medical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Kwara, Nigeria.
Progress in brain research
|August 21, 2024
概括
咖啡消费可能提供神经保护,防止帕金森病 (PD). 咖啡中的化合物,如咖啡因,可以通过影响α-synuclein和肠道微生物群来减少PD发生率和症状.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元损失和α-synuclein聚合,导致运动和认知缺陷.
- 目前对PD的治疗方法在阻止疾病进展方面有限.
- 流行病学数据表明,咖啡消费与PD发病率降低有关.
研究的目的:
- 审查咖啡在帕金森病中的神经保护作用.
- 探索咖啡的生物活性化合物及其对抗α-synuclein的机制.
- 为了检查肠道微生物群在咖啡抗帕金森症作用中的作用.
主要方法:
- 流行病学研究和实验研究的文献综述.
- 分析咖啡的生物活性成分,包括咖啡因,酸和cafestol.
- 研究微生物群-肠-大脑轴与PD和咖啡有关.
主要成果:
- 咖啡因和其他咖啡化合物对PD具有神经保护性.
- 咖啡消费与较低的PD发病率相关,这可能是由于咖啡因的影响.
- 咖啡的摄入影响肠道微生物群的组成,可能减轻炎症和蛋白质错折.
结论:
- 咖啡及其成分在控制帕金森病的症状和进展方面表现有前途.
- 咖啡对肠道微生物组的调节作用代表了PD的潜在治疗途径.
- 对咖啡的成分和微生物群-肠-大脑轴的进一步研究对于PD治疗策略是有必要的.
相关概念视频
Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
Parkinson's Disease: Overview
500
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Psychoneuroimmunology: Diabetes and Cancer
27
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
27


